Women at high risk of breast cancer is better identified by molecular subtyping

A new study led by the university of South Florida reported that, a new technique known as molecular sub-typing is of great help to professional doctors to determine which, if their breast cancer sufferers are at high risk of receiving breast cancer another time. Actually, this advanced genetic profiling offers an extra resource which helps the doctors to know about the patients who are more advantageous from chemotherapy and about those who would not. It is said by principal investigator Charles E. Cox, MD, McCann Foundation Endowed Professor of Breast Surgery, USF Health Morsani College of Medicine that, “The most important takeaway for our colleagues in breast cancer diagnosis and treatment is the potential value of molecular sub-typing to personalize and improve each woman’s treatment.” In fact, molecular sub-typing is a method of classifying the tumors of breast cancer into 1-4 genetically different categories, or sub-types like Luminal A, B and HER2-type from which some present the higher risk of cancer recurrence.